lobbying_activities: 1451177

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1451177	4152e43a-7e49-44a2-843f-d5946007b0ad	Q3	EVERGREEN ASSOCIATES, LTD.	13984	PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION	2013	third_quarter	PHA	- RIN: 0910-AG18, Electronic Distribution of Content Labeling for Human Prescription Drug and Biological Products - Risk Communications: Consumer Medication Information, Medication Guides, Patient Package Inserts, Professional Inserts - P.L. 112-144: Food and Drug Administration Safety and Innovation Act: Title XI- Other Provisions, Subtitle C- Miscellaneous Provisions, Sec. 1140- Study on Drug Labeling by Electronic Means- HR 1919: Safeguarding Americas Pharmaceuticals Act of 2013: Section 8- Electronic labeling - S 957: Drug Supply Chain Security Act - S 959: Pharmaceutical Compounding and Accountability Act - H.R. 3204: Drug Quality and Security Act	Food & Drug Administration (FDA),Government Accountability Office (GAO),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE	10000		0	0	2013-10-18T12:28:58.580000-04:00